000 | 03177cam a2200577Ii 4500 | ||
---|---|---|---|
001 | 9780429490545 | ||
003 | FlBoTFG | ||
005 | 20220711212427.0 | ||
006 | m o d | ||
007 | cr cnu---unuuu | ||
008 | 190110s2019 si ob 001 0 eng d | ||
040 |
_aOCoLC-P _beng _erda _epn _cOCoLC-P |
||
020 |
_a9780429490545 _q(electronic bk.) |
||
020 |
_a0429490542 _q(electronic bk.) |
||
020 |
_a9780429955211 _q(electronic bk. : EPUB) |
||
020 |
_a0429955219 _q(electronic bk. : EPUB) |
||
020 |
_a9780429955228 _q(electronic bk. : PDF) |
||
020 |
_a0429955227 _q(electronic bk. : PDF) |
||
020 |
_a9780429955204 _q(electronic bk. : Mobipocket) |
||
020 |
_a0429955200 _q(electronic bk. : Mobipocket) |
||
020 | _z9789814774925 | ||
020 | _z9814774928 | ||
035 | _a(OCoLC)1081315262 | ||
035 | _a(OCoLC-P)1081315262 | ||
050 | 4 | _aRS199.5 | |
072 | 7 |
_aMED _x071000 _2bisacsh |
|
072 | 7 |
_aMED _x000000 _2bisacsh |
|
072 | 7 |
_aMED _x002000 _2bisacsh |
|
072 | 7 |
_aMED _x009000 _2bisacsh |
|
072 | 7 |
_aMQW _2bicssc |
|
082 | 0 | 4 |
_a615.6 _223 |
245 | 0 | 0 |
_aDrug delivery nanosystems : _bfrom bioinspiration and biomimetics to clinical applications / _cedited by Natassa Pippa, Costas Demetzos, Stergios Pispas. |
264 | 1 |
_aSingapore : _bPan Stanford Publishing, _c[2019] |
|
300 | _a1 online resource (1 volume.) | ||
336 |
_atext _btxt _2rdacontent |
||
337 |
_acomputer _bc _2rdamedia |
||
338 |
_aonline resource _bcr _2rdacarrier |
||
520 | _aNanotechnology seeks to exploit distinct technological advances controlling the structure of nanoscale biomaterials at a nanodimensional scale approaching individual molecules and their aggregates or supramolecular structures. The term "nanomedicine" is used to describe those technologies under the umbrella of nanotechnology that have therapeutic applications in human health. This book presents recent trends and research achievements in the field of pharmaceutical nanotechnology and advanced drug delivery nanosystems, especially for theranostic purposes. The applications of drug delivery nanosystems considered carriers of active pharmaceutical ingredients (APIs) (e.g., proteins, peptides, and nucleic acids) are analyzed on the basis of technology, preparation protocols, and biomedical applications. The book also extensively reports on the principles, design protocols, and applications of nanosystems in drug delivery, imaging, and targeting of active molecules of pharmaceutical interest. | ||
588 | _aOCLC-licensed vendor bibliographic record. | ||
650 | 0 |
_aDrug delivery systems. _97290 |
|
650 | 7 |
_aMEDICAL / Pharmacology _2bisacsh _97291 |
|
650 | 7 |
_aMEDICAL / General _2bisacsh _913341 |
|
650 | 7 |
_aMEDICAL / Administration _2bisacsh _916446 |
|
650 | 7 |
_aMEDICAL / Biotechnology _2bisacsh _916447 |
|
700 | 1 |
_aDemetzos, Costas, _eeditor. _916448 |
|
700 | 1 |
_aPippa, Natassa, _eeditor. _916449 |
|
700 | 1 |
_aPispas, Stergios, _d1967- _eeditor. _916450 |
|
856 | 4 | 0 |
_3Taylor & Francis _uhttps://www.taylorfrancis.com/books/9780429490545 |
856 | 4 | 2 |
_3OCLC metadata license agreement _uhttp://www.oclc.org/content/dam/oclc/forms/terms/vbrl-201703.pdf |
942 | _cEBK | ||
999 |
_c71258 _d71258 |